Article Information
History
- July 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chrispin Chaguza1,‡,*,
- Anne M. Hahn1,*,
- Mary E. Petrone1,2,*,
- Shuntai Zhou3,4,
- David Ferguson5,
- Mallery I. Breban1,
- Kien Pham1,
- Mario A. Peña-Hernández6,
- Christopher Castaldi7,
- Verity Hill1,
- Yale SARS-CoV-2 Genomic Surveillance Initiative†,
- Wade Schulz5,8,
- Ronald I. Swanstrom4,9,
- Scott C. Roberts10 and
- Nathan D. Grubaugh1,11,‡,#@
- 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 2School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia
- 3Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA
- 4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 5Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
- 6Department of Biological and Biomedical Sciences, Yale School of Medicine, New Haven, Connecticut, USA
- 7Yale Center for Genome Analysis, Yale University, New Haven, CT, USA
- 8Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
- 9Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 10Infectious Disease, Yale School of Medicine, New Haven, CT, USA
- 11Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA
- ↵‡Correspondence: chrispin.chaguza{at}yale.edu (C.C.) and nathan.grubaugh{at}yale.edu (N.D.G.)
↵* These authors contributed equally